TY - JOUR
T1 - Opiate use and escalation of care in hospitalized adults with acute heart failure and sleep-disordered breathing (Opiates HF Study)
AU - Niroula, Abesh
AU - Garvia, Veronica
AU - Rives-Sanchez, Marisela
AU - Quintos, Abigail
AU - Decker, Meredith
AU - Willes, Leslee
AU - Quan, Stuart F.
AU - Sharma, Sunil
N1 - Publisher Copyright:
Copyright © 2019 by the American Thoracic Society.
PY - 2019
Y1 - 2019
N2 - Rationale: Sleep-disordered breathing (SDB) is highly prevalent in adults hospitalized with acute heart failure. Data are limited on the implications of inadvertent opiate use in this population. Objectives: To determine the prevalence and impact of in-hospital opiate use in adults hospitalized for acute heart failure. Methods: From a prospective sleep registry, we selected a sequential group of adult participants who were admitted to the hospital for acute heart failure and received a portable sleep study (PSS) after screening for SDB using the STOP-BANG questionnaire. A retrospective review of charts was performed to assess use of opiates, need for escalation of care (defined as transfer to the intensive care unit [ICU]), 30-day readmission, and length of stay. A logistic regression model was used to calculate propensity scores for each participant with a screening apnea- hypopnea index (AHI) greater than or equal to 10/h. Study endpoints, including escalation of care to the ICU and 30-day hospital readmission, were compared using a x2 test with stabilized inverse probability-weighted propensity scores to control for potential confounding variables. Results: A total of 301 consecutive adults admitted with acute heart failure between November 2016 and October 2017 underwent PSS after SDB screening. Overall, 125 of 301 (41.5%) received opiates in the hospital, and 149 (49.5%) patients had an AHI greater than or equal to 10/h by PSS (high risk of SDB). In this high-risk group, 47 of 149 (32%) received opiates. Among those with an AHI greater than or equal to 10/h, escalation of care occurred in 12 of 47 (26%) of those who received opiates versus 4 of 102 (4%) of those who did not (P<0.001; weighted estimate of treatment difference, 23.5%; 95% confidence interval [CI], 9.9 to 37.2). Similarly, readmission within 30 days occurred in 7 of 47 (15%) of those who received opiates versus 9 of 102 (9%) of those who did not (P = 0.14; weighted estimate of treatment difference, 8.3%; 95% CI, 24.0 to 20.6). Mean length of stay (days) did not differ between groups (P = 0.61; weighted estimate of treatment difference, 20.3 d; 95% CI, 21.4 to 0.8). Conclusions: In adults admitted with acute heart failure and found to be at high risk of SDB, opiate use in the hospital was highly prevalent and was associated with a greater likelihood of escalation of care.
AB - Rationale: Sleep-disordered breathing (SDB) is highly prevalent in adults hospitalized with acute heart failure. Data are limited on the implications of inadvertent opiate use in this population. Objectives: To determine the prevalence and impact of in-hospital opiate use in adults hospitalized for acute heart failure. Methods: From a prospective sleep registry, we selected a sequential group of adult participants who were admitted to the hospital for acute heart failure and received a portable sleep study (PSS) after screening for SDB using the STOP-BANG questionnaire. A retrospective review of charts was performed to assess use of opiates, need for escalation of care (defined as transfer to the intensive care unit [ICU]), 30-day readmission, and length of stay. A logistic regression model was used to calculate propensity scores for each participant with a screening apnea- hypopnea index (AHI) greater than or equal to 10/h. Study endpoints, including escalation of care to the ICU and 30-day hospital readmission, were compared using a x2 test with stabilized inverse probability-weighted propensity scores to control for potential confounding variables. Results: A total of 301 consecutive adults admitted with acute heart failure between November 2016 and October 2017 underwent PSS after SDB screening. Overall, 125 of 301 (41.5%) received opiates in the hospital, and 149 (49.5%) patients had an AHI greater than or equal to 10/h by PSS (high risk of SDB). In this high-risk group, 47 of 149 (32%) received opiates. Among those with an AHI greater than or equal to 10/h, escalation of care occurred in 12 of 47 (26%) of those who received opiates versus 4 of 102 (4%) of those who did not (P<0.001; weighted estimate of treatment difference, 23.5%; 95% confidence interval [CI], 9.9 to 37.2). Similarly, readmission within 30 days occurred in 7 of 47 (15%) of those who received opiates versus 9 of 102 (9%) of those who did not (P = 0.14; weighted estimate of treatment difference, 8.3%; 95% CI, 24.0 to 20.6). Mean length of stay (days) did not differ between groups (P = 0.61; weighted estimate of treatment difference, 20.3 d; 95% CI, 21.4 to 0.8). Conclusions: In adults admitted with acute heart failure and found to be at high risk of SDB, opiate use in the hospital was highly prevalent and was associated with a greater likelihood of escalation of care.
KW - Heart failure
KW - Opiates
KW - Outcomes
KW - Sleep
KW - Sleep-disordered breathing
UR - http://www.scopus.com/inward/record.url?scp=85071788284&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071788284&partnerID=8YFLogxK
U2 - 10.1513/AnnalsATS.201902-100OC
DO - 10.1513/AnnalsATS.201902-100OC
M3 - Article
C2 - 31184503
AN - SCOPUS:85071788284
SN - 2325-6621
VL - 16
SP - 1165
EP - 1170
JO - Annals of the American Thoracic Society
JF - Annals of the American Thoracic Society
IS - 9
ER -